share_log

Vanda Pharmaceuticals Granted U.S. Patent Titled 'Treatment of circadian rhythm disorders'

Benzinga Real-time News ·  Mar 16, 2021 23:46
Vanda Pharmaceuticals Granted U.S. Patent Titled 'Treatment of circadian rhythm disorders'
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment